Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and Safety of Low-dose Spironolactone for Chronic Kidney Disease in Type 2 Diabetes

PaperCitations, authors & open-access status

Efficacy and Safety of Low-dose Spironolactone for Chronic Kidney Disease in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 21 citations, 2023 year and bronze oa status.

21
Citations
2023
Year
bronze
OA Status

Related on ScholarIQ

Masanori Yamazaki
Author
Takahide Miyamoto
Author
Masayoshi Koinuma
Author
Teiji Takeda
Author
Mitsuhisa Komatsu
Author
The Journal of Clinical Endocrinology & Metabolism
Journal
470M+ articles · free account